These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 36602322

  • 1. In Vitro Activity of Ceftibuten-Avibactam against β-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program.
    Karlowsky JA, Hackel MA, Stone GG, Sahm DF.
    Antimicrob Agents Chemother; 2023 Jan 24; 67(1):e0134622. PubMed ID: 36602322
    [Abstract] [Full Text] [Related]

  • 2. Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-β-Lactamase-Positive Clinical Isolates of Enterobacterales from a 2018-2020 Global Surveillance Collection.
    Karlowsky JA, Wise MG, Hackel MA, Pevear DC, Moeck G, Sahm DF.
    Antimicrob Agents Chemother; 2022 Nov 15; 66(11):e0093422. PubMed ID: 36286518
    [Abstract] [Full Text] [Related]

  • 3. In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales.
    Karlowsky JA, Hackel MA, Sahm DF.
    Antimicrob Agents Chemother; 2022 Jan 18; 66(1):e0130421. PubMed ID: 34662183
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015.
    Kazmierczak KM, Bradford PA, Stone GG, de Jonge BLM, Sahm DF.
    Antimicrob Agents Chemother; 2018 Dec 18; 62(12):. PubMed ID: 30249690
    [Abstract] [Full Text] [Related]

  • 8. Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Enterobacterales Clinical Isolates.
    Han R, Yang X, Yang Y, Guo Y, Yin D, Ding L, Wu S, Zhu D, Hu F.
    Microbiol Spectr; 2022 Feb 23; 10(1):e0109221. PubMed ID: 35019685
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017-2019.
    Karlowsky JA, Kazmierczak KM, Valente MLNF, Luengas EL, Baudrit M, Quintana A, Irani P, Stone GG, Sahm DF.
    Braz J Infect Dis; 2021 Feb 23; 25(6):101647. PubMed ID: 34774471
    [Abstract] [Full Text] [Related]

  • 10. In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015.
    Karlowsky JA, Kazmierczak KM, Bouchillon SK, de Jonge BLM, Stone GG, Sahm DF.
    Antimicrob Agents Chemother; 2018 Jul 23; 62(7):. PubMed ID: 29760124
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021).
    Sader HS, Carvalhaes CG, Huband MD, Mendes RE, Castanheira M.
    Eur J Clin Microbiol Infect Dis; 2023 Apr 23; 42(4):453-459. PubMed ID: 36810724
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial Activity of Ceftazidime-Avibactam and Comparators against Pathogens Harboring OXA-48 and AmpC Alone or in Combination with Other β-Lactamases Collected from Phase 3 Clinical Trials and an International Surveillance Program.
    Lin LY, Debabov D, Chang W, Stone G, Riccobene T.
    Antimicrob Agents Chemother; 2022 Mar 15; 66(3):e0198521. PubMed ID: 35225651
    [Abstract] [Full Text] [Related]

  • 13. Selection of mutants with resistance or diminished susceptibility to ceftazidime/avibactam from ESBL- and AmpC-producing Enterobacteriaceae.
    Livermore DM, Mushtaq S, Doumith M, Jamrozy D, Nichols WW, Woodford N.
    J Antimicrob Chemother; 2018 Dec 01; 73(12):3336-3345. PubMed ID: 30247546
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021.
    Wise MG, Karlowsky JA, Mohamed N, Kamat S, Sahm DF.
    Eur J Clin Microbiol Infect Dis; 2023 Sep 01; 42(9):1135-1143. PubMed ID: 37526796
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam: Data from the Antimicrobial Testing Leadership and Surveillance Programme, 2012-2019.
    Jean SS, Lee YL, Hsu CW, Hsueh PR.
    Int J Antimicrob Agents; 2022 Sep 01; 60(3):106617. PubMed ID: 35718266
    [Abstract] [Full Text] [Related]

  • 18. Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.
    Dupont H, Gaillot O, Goetgheluck AS, Plassart C, Emond JP, Lecuru M, Gaillard N, Derdouri S, Lemaire B, Girard de Courtilles M, Cattoir V, Mammeri H.
    Antimicrob Agents Chemother; 2016 Jan 01; 60(1):215-21. PubMed ID: 26482307
    [Abstract] [Full Text] [Related]

  • 19. Ceftazidime-Avibactam Antimicrobial Activity and Spectrum When Tested Against Gram-negative Organisms From Pediatric Patients: Results From the INFORM Surveillance Program (United States, 2011-2015).
    Sader HS, Huband MD, Duncan LR, Flamm RK.
    Pediatr Infect Dis J; 2018 Jun 01; 37(6):549-554. PubMed ID: 29206750
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of ceftazidime/avibactam against isolates of Enterobacteriaceae collected in European countries: INFORM global surveillance 2012-15.
    Kazmierczak KM, de Jonge BLM, Stone GG, Sahm DF.
    J Antimicrob Chemother; 2018 Oct 01; 73(10):2782-2788. PubMed ID: 30010894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.